Nonadherence to Imatinib adversely affects event free survival in chronic phase chronic myeloid leukemia
Author:
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.22019/fullpdf
Reference15 articles.
1. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia;Druker;N Engl J Med,2006
2. Optimizing therapy for patients with chronic myelogenous leukemia in chronic phase;Kantarjian;Cancer,2010
3. Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: TheADAGIO study;Noens;Blood,2009
4. Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib;Marin;J Clin Oncol
5. Treatment interruptions and non-adherence with imatinib and associated healthcare costs: A retrospective analysis among managed care patients with chronic myelogenous leukaemia;Darkow;Pharmacoeconomics,2007
Cited by 153 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Adherence to Chemotherapy and Associated Factors among Patients with Cancer in the Amhara Region, Northeast Ethiopia, 2022.;2024-01-31
2. Protocol of a patient randomized clinical trial to improve medication adherence in primary care;Contemporary Clinical Trials;2024-01
3. Treatment and follow‐up of children with chronic myeloid leukaemia in chronic phase (CML‐CP) in the tyrosine kinase inhibitor (TKI) era—Two decades of experience from the Tata Memorial Hospital paediatric CML (pCML) cohort;British Journal of Haematology;2023-12-14
4. Feasibility, acceptability, and potential effects of a digital oral anticancer agent intervention: A pilot randomized controlled trial protocol (Preprint);2023-12-13
5. Patient Adherence to Oral Anticancer Agents: A Mapping Review of Supportive Interventions;Current Oncology;2023-11-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3